Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (BBNX)

CUSIP: 08659B102

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
-1,176,529
SEC-reported price per share
$30.47
Number of holders
159
Value change
+$22,363,225
Number of buys
104
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
44,369,313

Security key

08659B102

Report period

Q4 2025

Institutions

159

Top holders

10

Ownership snapshot

Top reported holders of BBNX - Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Zone Healthcare Holdings,...
Disclosed value leader
EVENTIDE ASSET MANAGEMENT...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 9.9% 13D/G row: Zone Healthcare Holdings, LLC Showing 1-6 of 15 holder rows.

Quick read

Zone Healthcare Holdings, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Zone Healthcare Holdings, LLC's linked filing trail.
Comparable ownership Top 5
Zone Healthcare Holdings, LLC 9.9%
MORGAN STANLEY 8.6%
Sands Capital Life Sciences Pulse... 8.2%
BlackRock, Inc. 6.4%
PERCEPTIVE ADVISORS LLC 3.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Zone Healthcare Holdings, LLC
13D/G
Dapice Joshua J.
9.9%
$85,717,590
4,313,920 shares
+$17,618,729 30 Sep 2025
MORGAN STANLEY
13F 13D/G
Company
8.6%
from 13D/G
$74,742,654
3,761,583 shares
30 Sep 2025
Sands Capital Life Sciences Pulse Fund II, L.P.
13D/G
8.2%
$48,410,732
3,570,113 shares
+$5,636,946 30 Jun 2025
BlackRock, Inc.
13F 13D/G
Company
6.4%
from 13D/G
$55,265,048
2,781,331 shares
30 Sep 2025
PERCEPTIVE ADVISORS LLC
13D/G 13F
Company
3.7%
$21,609,324
1,593,608 shares
$0 31 Mar 2025
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
1.8%
$15,835,993
796,964 shares
-$29,602,207 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
159
Shares
47,221,349
Rows available
159
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
127
Q4 2025 holders
159
Holder diff
32
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .